Scientific News

  • New ERN RARE-LIVER Paper on PSVD - Journal of Hepatology

    Porto-sinusoidal vascular liver disorder (PSVD) is a rare liver condition that often leads to severe complications from portal hypertension and can reduce life expectancy.

    Read More
  • For Physicians: New ERN RARE-LIVER Survey on Alcohol Use

    ERN RARE-LIVER has constructed the survey “Counselling Young Adults With Liver Disease On Alcohol Use”. The survey will be open until 8 September, 2024. It consists of max. 10 pages and it will take 10 to 15 minutes to respond.

    Read More
  • Funding opportunity for clinical exchange

    The UEG (United European Gastroenterology) is offering clinical visiting fellowships to young doctors. You can apply to visit a European centre of excellence from a given list of hosts including a number of ERN RARE-LIVER member. This programme allows fellows

    Read More
  • New CPSS Position Paper

    Congenital portosystemic shunts are often associated with systemic complications, the most challenging of which are liver nodules, pulmonary hypertension, endocrine abnormalities, and neurocognitive dysfunction.

    Read More
  • EU4Health funding opportunity for orphan medical devices

    The Call for proposals of a program on orphan medical devices, in particular targeting paediatric patients by EU4Health is currently open and might be interesting for ERN RARE-LIVER members and partners. The grant will fund two projects over 1 up

    Read More
  • New Video on how to use EBAR - The European Biliary Atresia Registry of the ERN RARE-LIVER

    Biliary Atresia (BA) is a rare paediatric liver disease with an estimated prevalence of 1 / 14.000-21.000 births in Europe (~ 270 cases / year). Its aetiology is still unknown but recent studies favour an aetiology through microbe- or toxin-triggered immune dysregulation in liver and bile ducts leading to obliteration and fibrosis.

    Read More
  • Current transition management of adolescents and young adults with Liver Diseases: an ERN RARE-LIVER survey

    Substantial advances in the diagnosis, treatment, and long-term care of children presenting paediatric liver disease mean that survival into adulthood is now the expectation rather than the exception.

    Read More

Archive

Open Letter addressed to the European Commission
Read More
3rd Wilson Aarhus Symposium 2-5 May 2024
Read More
5th Autoimmune Hepatitis Research Workshop on 27 & 28 June 2024
Read More
New Hepatic Alveolar Echinococcosis Working Group
Read More
Biliary Atresia Register planned
Read More
Young Investigator Workshop on Basic Science and Translational immunology in PSC
Read More
Immuno-oncology (IO) in patients with autoimmune liver disease (AILD)
Read More
Unconventional treatment of Autoimmune Hepatitis
Read More
Rivaroxaban Prophylaxis in Non-cirrhotic Portal Vein Thrombosis
Read More
Alpha1-antitrypsin deficiency (AATD) - associated liver disease
Read More
Results of the EU survey on the availability of age-appropriate medication for children with autoimmune liver disease (AILD)
Read More
Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: a patient-oriented online survey performed by ERN RARE-LIVER
Read More
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience
Read More
Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER
Read More
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.
Read More
Incident Gallstones During Somatostatin Analog
Read More
Study of ARO-AAT in Patients with Alpha-1 Antitrypsin Deficiency Associated Liver Dieseae (AATD)
Read More
SARS-CoV-2 infection in patients with autoimmune hepatitis
Read More
Adeno-associated virus (AAV) based gene therapy in Wilson's disease
Read More
Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age
Read More
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Read More
Second-line and Third-line therapy for Autoimmune Hepatitis A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group
Read More
Study on liver involvement in mild alpha1-antitrypsin deficiency published in "Gastroenterology”
Read More
A comprehensive characterization of liver involvement in alpha1-antitrypsin deficiency published in "Gastroenterology”
Read More
Efficacy and safety of selective decontamination of the digestive tract (SDD)
Read More
Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
Read More
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
Read More
Cross-sectional screening study for Biliary Atresia (BA)
Read More
Immune suppressed patients during the COVID 19 outbreak
Read More
A retrospective study on cancer surveillance in patients with PSC
Read More
Polycystic Kidney and Liver Disease
Read More
Novel pharmacologic treatment approaches targeting fibrogenesis
Read More
Alpha1-antitrypsin
Read More
Optimal transplantation in paediatric rare liver diseases
Read More
Disease activity and fibrosis in patients with AIH
Read More
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Read More